HPS Pharmacies wish to advise that Arrow Pharma is experiencing a supply interruption for Septrin® as follows:
Septrin® Oral Liquid
Trimethoprim + sulfamethoxazole 40mg+200mg/5mL
Normal supplies of Septrin® Oral Liquid are expected to resume by mid-June 2023.
An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. This product is identical to the Australian-registered product for active ingredients, strength, and pack size.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Arrow Pharma on 1800 195 055, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates